跳至主要内容
临床试验/NCT01749501
NCT01749501已完成4 期

Premedication for Non-Emergency Endotracheal Intubation In the NICU

Martin Espinosa, MD0 个研究点目标入组 45 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
45
主要终点
Present the Percentage of Participants With an Excellent Ease of Intubation Rating

研究概览

简要总结

Those infants who received the muscle relaxation in combination with the vagolytic (reduce vagus nerve impulses) and pain medication will have reduced time to successful intubation (placement of tube into the lungs), a decrease in the number of attempts, and better intubation conditions reported by the practitioner. The objectives of the study include: 1.) Does the medication protocol outlined in this study provide optimal intubation conditions? (i.e.good jaw relaxation, open and immobile vocal cords and suppression of gag reflex) 2.) Does the addition of a muscle relaxant prior to intubation contribute to less attempts and achieving successful intubation as opposed to neonates who do not receive the muscle relaxant.

详细描述

The investigators project will study two different strategies of pre-medication in an attempt to eliminate the pain and discomfort associated with the elective intubation procedure. The study will be blinded and patients will be randomized in two different arms according to gestational age and identified by study number for pre-medication protocols. Demographic as well as study information prior, during and post intubation attempt will be recorded and closely monitored. Each patient will be monitored for study purposes for at least 24 hours after intubation attempt to record any potential side effects of the medication. The investigators plan to have a data safety monitoring board established composed of three pediatric doctors / specialists not associated with this study.

The response of paralysis, onset and duration will be assessed clinically. Onset of muscle relaxation will be described as the absence of spontaneous movements and flaccidity, measured in seconds from the end of the medication administration. Duration of paralysis will be determined by the difference in time from the onset of paralysis to the return of spontaneous movements and pre-intubation tone

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Rocuronium

Active Comparator

0.6 mg/kg once

干预措施: Rocuronium (Drug)

Placebo

Placebo Comparator

Placebo

干预措施: Placebo (Other)

结局指标

主要结局

Present the Percentage of Participants With an Excellent Ease of Intubation Rating

时间窗: 24 hours after intubation period

percentage of participants with an excellent ease of intubation rating based on Scale of 1-4 (1 Being Excellent, 4 Being Poor),"

次要结局

  • Timing of Entire Procedure (Stopwatch)and Recording Number of Attempts to Successful Intubation Recorded.(24 hours after intubation procedure)

研究者

发起方
Martin Espinosa, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Martin Espinosa, MD

Principal Investigator

William Beaumont Hospitals

相似试验